INS and obstructive sleep apnea syndrome: As with mean medication use, insulin use for T2DM went down (postoperative insulin use at 24.8%) and CPAP or BiPAP use for OSA also declined (postoperative CPAP/BiPAP use at 13.7%) (all P < .001 for preoperative vs. postoperative use comparison).